Brokerages Set GE HealthCare Technologies Inc. (NASDAQ:GEHC) Price Target at $95.46

Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) have received a consensus rating of “Moderate Buy” from the fourteen ratings firms that are covering the firm, Marketbeat Ratings reports. One analyst has rated the stock with a sell rating, four have issued a hold rating, eight have assigned a buy rating and one has assigned a strong buy rating to the company. The average 1 year target price among analysts that have issued a report on the stock in the last year is $95.46.

Several brokerages have recently issued reports on GEHC. UBS Group downgraded shares of GE HealthCare Technologies from a “neutral” rating to a “sell” rating and dropped their target price for the stock from $84.00 to $74.00 in a research note on Thursday, September 26th. BTIG Research raised GE HealthCare Technologies from a “neutral” rating to a “buy” rating and set a $100.00 price objective on the stock in a research report on Wednesday, September 18th. Evercore ISI lifted their target price on GE HealthCare Technologies from $98.00 to $102.00 and gave the stock an “outperform” rating in a report on Tuesday, October 1st. Wells Fargo & Company upped their price target on GE HealthCare Technologies from $95.00 to $96.00 and gave the company an “overweight” rating in a report on Thursday, October 31st. Finally, Stifel Nicolaus lifted their price objective on GE HealthCare Technologies from $100.00 to $102.00 and gave the stock a “buy” rating in a report on Monday, September 30th.

Insider Transactions at GE HealthCare Technologies

In related news, CEO Roland Rott sold 3,577 shares of the stock in a transaction that occurred on Wednesday, November 6th. The shares were sold at an average price of $86.48, for a total value of $309,338.96. Following the completion of the sale, the chief executive officer now directly owns 24,298 shares of the company’s stock, valued at approximately $2,101,291.04. This represents a 12.83 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. 0.27% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On GE HealthCare Technologies

A number of hedge funds have recently modified their holdings of the company. Nordea Investment Management AB lifted its stake in shares of GE HealthCare Technologies by 30.2% during the 4th quarter. Nordea Investment Management AB now owns 43,632 shares of the company’s stock valued at $3,429,000 after buying an additional 10,116 shares in the last quarter. Everence Capital Management Inc. lifted its position in shares of GE HealthCare Technologies by 118.2% in the fourth quarter. Everence Capital Management Inc. now owns 18,870 shares of the company’s stock valued at $1,475,000 after acquiring an additional 10,220 shares in the last quarter. GAMMA Investing LLC boosted its stake in shares of GE HealthCare Technologies by 4.6% in the fourth quarter. GAMMA Investing LLC now owns 8,016 shares of the company’s stock worth $627,000 after acquiring an additional 355 shares during the period. Versant Capital Management Inc grew its position in shares of GE HealthCare Technologies by 19.0% during the fourth quarter. Versant Capital Management Inc now owns 6,125 shares of the company’s stock worth $479,000 after purchasing an additional 980 shares in the last quarter. Finally, Cacti Asset Management LLC raised its stake in GE HealthCare Technologies by 9.4% during the 4th quarter. Cacti Asset Management LLC now owns 2,916 shares of the company’s stock valued at $229,000 after purchasing an additional 250 shares during the period. 82.06% of the stock is currently owned by institutional investors.

GE HealthCare Technologies Stock Up 2.0 %

GEHC stock opened at $83.37 on Friday. The business has a 50 day moving average of $82.33 and a 200 day moving average of $84.02. The firm has a market cap of $38.09 billion, a PE ratio of 22.90, a price-to-earnings-growth ratio of 2.90 and a beta of 1.11. GE HealthCare Technologies has a twelve month low of $71.31 and a twelve month high of $94.55. The company has a quick ratio of 0.98, a current ratio of 1.23 and a debt-to-equity ratio of 1.12.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its quarterly earnings results on Wednesday, October 30th. The company reported $1.14 earnings per share for the quarter, beating the consensus estimate of $1.06 by $0.08. The firm had revenue of $4.86 billion during the quarter, compared to the consensus estimate of $4.87 billion. GE HealthCare Technologies had a return on equity of 25.19% and a net margin of 8.56%. The company’s revenue was up .9% on a year-over-year basis. During the same period last year, the company earned $0.99 earnings per share. On average, research analysts forecast that GE HealthCare Technologies will post 4.3 EPS for the current fiscal year.

GE HealthCare Technologies Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Tuesday, January 14th will be given a dividend of $0.035 per share. This is an increase from GE HealthCare Technologies’s previous quarterly dividend of $0.03. The ex-dividend date is Tuesday, January 14th. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.17%. GE HealthCare Technologies’s payout ratio is presently 3.85%.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.